Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis.

Hamdy Khaled SabraGehad S RemeihIbraheem M KereetMohammad HamadYassmien Ali AhmedKainat JahangirMostafa Abdulraheem BakrFatma Assad AlagelliHadeer SherifMohamed Elsaid

Published in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2024)

Despite the small number of patients in the included studies and variable follow-up duration, GLP-2 seems to be safe and effective in patients with SBS. GLP-2 showed a positive effect on increasing plasma citrulline level and decreasing ALP level.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes